Biodel Corporation - Results of Linjeta(TM) Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting
Links shared publicly online about this topic.
- 857total visits
Biodel Corporation - Results of Linjeta(TM) Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting
View full resource at investor.biodel.com
Tags: Insulin
Most Recently Shared on September 21, 2010 at 1:11 pm By:
Biodel Results of Linjeta Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Meeting: http://bit.ly/dzNg7i
Advertisement

